• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

Device-guided breathing not associated with improved blood pressure control

byShayna BejaimalandJames Jiang
September 17, 2014
in Cardiology, Chronic Disease
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Device-guided breathing was not associated with improved blood pressure as compared to active controls such as sham devices or music therapy.

2. Device guided breathing exercises may be a costly alternative to freely available relaxation techniques that may be equally efficacious.

Evidence Rating Level: 2 (Good)

Study Rundown: Given the negative impact of long-standing hypertension on cardiovascular health, it is important to discover effective pharmacological and non-pharmacological interventions. Newer approaches include slowing of breathing through device-guided breathing (DGB) exercises. These devices use musical tones to train one to slow their breathing. Previous studies have shown small short-term effects against inactive controls. However, this study sought to investigate the DGB’s efficacy against active controls, such as musical therapy and sham devices.

This meta-analysis did not find a significant association between office blood pressure improvements within their primary and secondary analyses of individual patient data and data from published articles. Overall risk of bias analysis determined that the two studies initiated by the manufacturer of the DGB device had a high risk of selective outcome reporting, as the primary outcome was analyzed with methods not determined a priori. Strengths of the study include using statistical meta-analytic techniques to re-analyze individual patient level data from single or double blinded RCTs, and also comparing DGB to active controls. However, the study was limited to lower quality RCTs with short follow-up. Consequently, no long-term cardiovascular end points were analyzed, and two of five studies were found to have a high risk of bias.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

A health coaching intervention may improve blood pressure control in postpartum women

2 Minute Medicine Rewind August 10, 2026

Relevant Reading: Device-guided breathing exercises in the control of human blood pressure: systematic review and meta-analysis

In-Depth [meta-analysis]: This meta-analysis identified five RCTs that were either single or double-blinded and compared DGB to active controls (sham device or music therapy). Four studies compared DGB to music therapy and one to a sham device. The commercial DGB device, called RESPeRATE, was used in all five RCTs, two of which were conducted by RESPeRATE’s manufacturer, Inter-Cure Ltd. The primary outcome was a change in office systolic blood pressure between baseline and end of treatment period. The secondary outcome was a change in diastolic pressure. Ideally, the primary analysis would include all individual patient data from all studies. However, for studies where this data could not be attained, secondary meta-analysis would include the study’s published unadjusted data.

The primary analysis, when corrected for study group, age, sex and body mass index, showed non-significant mean differences in inverse variance (95% CI) of 1.7 mmHg (-3.1 to 6.5) in favour of the control for systolic blood pressure and -0.7 mmHg (-3.6 to 2.1) in favour of the DGB for diastolic blood pressure. When the two additional positive manufacturer studies were included in the secondary analysis, the non-significant results remained with a mean difference in inverse variance (95% CI) of 1.1 (-2.8 to 5.0) in favour of DGB. Additionally, when specifically compared to music therapy, DGB did not significantly lower systolic or diastolic blood pressure, with differences of 1.8 mm Hg (-2.8 to 6.3) in favour of DGB and 1.6 mmHg (-2.3 to 5.4) in favour of DGB.

More from this author: Overall US diet quality improved from 1999 to 2010, Arterial catheter monitoring in ICU not associated with mortality benefit

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

 

Tags: blood pressure
Previous Post

Antenatal magnesium sulfate may not improve pediatric neurodevelopment

Next Post

Fecal transplantation in recurrent C. difficile infection [Classics Series]

RelatedReports

Blood pressure collage: a large artery cross-section ring, a tipped salt cellar spilling crystals and a plain wristwatch
Cardiology

A health coaching intervention may improve blood pressure control in postpartum women

August 12, 2026
Sleep disorders collage: an engraved pillow and rumpled sheet with a dark sleep mask, a paper crescent moon and a teal ribbon
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Blood pressure collage: a large artery cross-section ring, a tipped salt cellar spilling crystals and a plain wristwatch
Cardiology

Efficiency of remote monitoring and guidance in blood pressure management

August 13, 2025
Downward trend in mortality rate for antineutrophil cytoplasmic autoantibody-associated vasculitis
AI Roundup

Becton Dickinson Unveils Artificial Intelligence Powered Monitor for Surgery

May 28, 2025
Next Post
Classics Series, Landmark Trials in Medicine

Fecal transplantation in recurrent C. difficile infection [Classics Series]

TASTE trial: Thrombus aspiration before PCI in STEMI does not reduce mortality

TASTE trial: Thrombus aspiration before PCI in STEMI does not reduce mortality

Most anticoagulants for venous thromboembolism similarly effective

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intraosseous cefuroxime (Ceftin) may improve tissue delivery compared to intravenous administration during total knee arthroplasty
  • 2 Minute Medicine Rewind November 2, 2026
  • Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.